S, A. , Rao, V.M. and P. R, S. 2025. A Prospective Cross-sectional study to evaluate the utility of Fibroscan and Serum Biomarkers (APRI, FIB-4) for Non-Invasive Diagnosis of Liver Fibrosis in Metabolic dysfunction associated fatty liver disease (MAFLD) patients in a tertiary care center. Journal of Neonatal Surgery. 14, 21S (May 2025), 848–854.